01583708 1.7.15 30.6.16 30.6.16 Company accounts Private Limited Company FY true false true false false true false A Ordinary 1.00000 B Ordinary 1.00000 C Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure015837082015-06-30015837082016-06-30015837082015-07-012016-06-30015837082014-06-30015837082014-07-012015-06-30015837082015-06-3001583708ns14:PoundSterling2015-07-012016-06-3001583708ns7:Director12015-07-012016-06-3001583708ns7:OrdinaryShareClass32015-07-012016-06-3001583708ns7:OrdinaryShareClass42015-07-012016-06-3001583708ns7:OrdinaryShareClass52015-07-012016-06-3001583708ns7:Director22015-07-012016-06-3001583708ns7:CompanySecretary2015-07-012016-06-3001583708ns7:RegisteredOffice2015-07-012016-06-3001583708ns7:EntityAccountantsOrAuditors2015-07-012016-06-3001583708ns5:PlantMachinery2015-07-012016-06-3001583708ns5:FixturesFittings2015-07-012016-06-3001583708ns7:OrdinaryShareClass32016-06-3001583708ns7:OrdinaryShareClass32015-06-3001583708ns7:OrdinaryShareClass42016-06-3001583708ns7:OrdinaryShareClass42015-06-3001583708ns7:OrdinaryShareClass52016-06-3001583708ns7:OrdinaryShareClass52015-06-30
REGISTERED NUMBER: 01583708












Abbreviated Unaudited Accounts

for the Year Ended 30 June 2016

for

Abtek (Biologicals) Limited

Abtek (Biologicals) Limited (Registered number: 01583708)






Contents of the Abbreviated Accounts
for the Year Ended 30 June 2016




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 4

Abtek (Biologicals) Limited

Company Information
for the Year Ended 30 June 2016







DIRECTORS: Mr R Turner
Mr S C Turner





SECRETARY: Mrs J M Turner





REGISTERED OFFICE: 145 Edge Lane
Liverpool
Merseyside
L7 2PG





REGISTERED NUMBER: 01583708





ACCOUNTANTS: Wilson Henry LLP
Chartered Accountants
145 Edge Lane
Liverpool
L7 2PF

Abtek (Biologicals) Limited (Registered number: 01583708)

Abbreviated Balance Sheet
30 June 2016

2016 2015
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 2 58,463 25,522

CURRENT ASSETS
Stocks 93,783 95,034
Debtors 155,097 85,962
Cash at bank 10,024 5,594
258,904 186,590
CREDITORS
Amounts falling due within one year 140,369 109,694
NET CURRENT ASSETS 118,535 76,896
TOTAL ASSETS LESS CURRENT
LIABILITIES

176,998

102,418

CREDITORS
Amounts falling due after more than one
year

(37,381

)

-

PROVISIONS FOR LIABILITIES (11,056 ) (4,746 )
NET ASSETS 128,561 97,672

CAPITAL AND RESERVES
Called up share capital 3 3,750 3,750
Other reserves - equity 10,024 10,024
Profit and loss account 114,787 83,898
SHAREHOLDERS' FUNDS 128,561 97,672

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2016.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2016 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the
Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at
the end of each financial year and of its profit or loss for each financial year in accordance with the
requirements of Sections 394 and 395 and which otherwise comply with the requirements of the
Companies Act 2006 relating to financial statements, so far as applicable to the company.

Abtek (Biologicals) Limited (Registered number: 01583708)

Abbreviated Balance Sheet - continued
30 June 2016


The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 30 March 2017 and were signed on its
behalf by:





Mr R Turner - Director


Abtek (Biologicals) Limited (Registered number: 01583708)

Notes to the Abbreviated Accounts
for the Year Ended 30 June 2016

1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance
with the Financial Reporting Standard for Smaller Entities (effective January 2015).

Turnover
Turnover represents net invoiced sales of goods, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery - 10% on cost
Fixtures and fittings - 10% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for
obsolete and slow moving items.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at
the balance sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to the profit and loss account on a straight line basis
over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the
company's pension scheme are charged to the profit and loss account in the period to which they
relate.

2. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1 July 2015 164,085
Additions 40,622
At 30 June 2016 204,707
DEPRECIATION
At 1 July 2015 138,563
Charge for year 7,681
At 30 June 2016 146,244
NET BOOK VALUE
At 30 June 2016 58,463
At 30 June 2015 25,522

Abtek (Biologicals) Limited (Registered number: 01583708)

Notes to the Abbreviated Accounts - continued
for the Year Ended 30 June 2016

3. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2016 2015
value: £    £   
1,950 A Ordinary £1 1,950 1,950
858 B Ordinary £1 858 858
942 C Ordinary £1 942 942
3,750 3,750